Citations with the tag: HIV (Viruses)

Results 51 - 100

  • Biological properties of a CD4 immunoadhesin.
    Byrn, R.A.; Mordenti, J. // Nature; 4/12/1990, Vol. 344 Issue 6267, p667 

    Demonstrates that a CD4 immunoadhesin can mediate antibody-dependent cell-mediated cytotoxicity towards human immunodeficiency virus (HIV)-infected cells. Methods; Results; Discussion.

  • Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum.
    Buonocore, L.; Rose, J.K. // Nature; 6/14/1990, Vol. 345 Issue 6276, p625 

    Demonstrates that expression of a soluble CD4 molecule, mutated to contain a specific retention signal for the endoplasmic reticulum, blocks secretion of gp120 and surface expression of gp120/41, but does not interfere with transport of wild-typeCD4.

  • Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.
    Southgate, C.; Zapp, M.L. // Nature; 6/14/1990, Vol. 345 Issue 6276, p640 

    Presents research reporting that HIV-1 Tat protein can activate transcription when bound to nascent RNA through the RNA-binding domain of another HIV-1 protein, Rev. Methods; Results; Discussion.

  • Blocking of Tat-dependent HIV-1 RNA modification by an inhibitor of RNA polymerase II processivity.
    Braddock, M.; Thorburn, A.M. // Nature; 4/4/1991, Vol. 350 Issue 6317, p439 

    Demonstrates that Tat activation of its target RNA in the nucleus involves a Tat-dependent covalent modification. Also finds that the nucleoside analogue 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole blocks this Tat-dependent modification.

  • Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines.
    Aldovini, A.; Young, R.A. // Nature; 6/6/1991, Vol. 351 Issue 6326, p479 

    Reports that a variety of human immunodeficiency virus (HIV) type 1 polypeptides can be expressed in `Mycobacterium bovis' bacillus Calmette-Guerin (BCG) recombinants under the control of mycobacterial hsp70 promoter. Foreign polypeptides produced in BCG can induce antibody and T-cell responses.

  • The spread of HIV-1 in Africa: Sexual contact patterns and the predicted demographic impact of AIDS.
    Anderson, R.; May, R.M. // Nature; 8/15/1991, Vol. 352 Issue 6336, p581 

    Examines the spread of the human immunodeficiency virus type 1 (HIV-1) in Africa. Epidemiology in Africa; Epidemiological parameters; Sexual behavior; Mathematical models; Discussion.

  • HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes.
    Bachelerie, F.; Alcamo, J. // Nature; 4/25/1991, Vol. 350 Issue 6320, p709 

    Demonstrates that chronic human immunodeficiency virus (HIV) infection results in both induction of a nuclear factor with antigenic properties indistinguishable from those of NF-kappa B and permanently increased HIV enhancer activity. This phenomenon is associated with HIV replication and may...

  • Human infection by genetically diverse SIVsm-related HIV-2 in West Africa.
    Gao, Feng; Yue, Ling // Nature; 8/6/1992, Vol. 358 Issue 6386, p495 

    Relates that our understanding of the biology and origins of HIV-2 derives from studies of cultured isolates from urban populations experiencing epidemic infection and disease. Tests the hypothesis that such isolates might represent only a subset of a larger, more genetically diverse group of...

  • Research presents hope for stopping HIV.
    Gao, Feng; Yue, Ling // Modern Healthcare; 6/24/96, Vol. 26 Issue 26, p88 

    Reports on the optimism of researchers that the HIV virus can be eradicated. Discussion of clinical trials demonstrating viral suppression at a conference held in June 1996; Factors for researchers' optimism.

  • One-on-one.
    Gao, Feng; Yue, Ling // Advocate; 12/12/95, Issue 696, p39 

    Presents advice on how actively HIV reproduces and the chances of developing AIDS. Design of tests that measure the amount of virus being produced by HIV-infected cells.

  • Court gives virus equal rights.
    Gao, Feng; Yue, Ling // Human Events; 07/10/98, Vol. 54 Issue 26, p1 

    Reports on the court case Bragdon v. Abbott in the Supreme Court of the United States, in which a dentist was charged with violating the rights of a human immunodeficency virus (HIV) patient. Circumstances surrounding the case; Comments from Sidney Abbott, patient; Reference to the Americans...

  • Priority on HIV.
    Gao, Feng; Yue, Ling // Nature; 11/30/1989, Vol. 342 Issue 6249, p462 

    Opinion. Discusses a report in the `Chicago Tribune' by journalist John Crewdson concerning who first discovered the virus responsible for AIDS. Robert Gallo of the United States has been given too much credit and French researcher Montagnier too little credit. Report resurrects the...

  • Is there a `successful' immune response to HIV?
    Brown, Phyllida // New Scientist; 7/4/92, Vol. 135 Issue 1828, p18 

    Reports on research by scientists at the National Cancer Institute that have begun small-scale studies on the immune systems of people who have been repeatedly exposed to HIV without apparently becoming infected. Men studied; Findings; Conclusion; Discovery of the crystal structure of the HIV's...

  • Genetic organization of a chimpanzee lentivirus related to HIV-1.
    Huet, T.; Cheynier, R. // Nature; 5/24/1990, Vol. 345 Issue 6273, p356 

    Describes the molecular cloning and sequencing of an infectious proviral clone of SIVCPZ lentivirus. Findings indicate that there is a larger pool of simian lentiviruses than previously suspected and revives the debate as to the origins of HIV-1.

  • Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives.
    Pauwels, R.; Andries, K. // Nature; 2/1/1990, Vol. 343 Issue 6257, p470 

    Investigates new anti-HIV (human immunodeficiency virus) compounds with acceptable pharmacology. Methods; Results; Discussion.

  • Processing of the precursor of NF-kB by the HIV-1 protease during acute infection.
    Riviere, Y.; Blank, V. // Nature; 4/18/1991, Vol. 350 Issue 6319, p625 

    Demonstrates that the human immunodeficiency virus type 1 (HIV-1) protease can process 105K precursor and increases in levels of active nuclear NF-kB complex. Experimental methods; Results; Discussion.

  • Living proof: Thinking positive.
    Riviere, Y.; Blank, V. // Seventeen; Dec92, Vol. 51 Issue 12, p48 

    Profiles people who are HIV-positive, their positive attitudes and how they are dealing with the diagnosis. Vanessa Clark, 25; Mary Hanerfeld; David Haney, 34; More.

  • A plague ignored.
    Zimmerman, Carlota // Russian Life; May97, Vol. 40 Issue 5, p6 

    Reports that as of March 1997, there were 3,327 officially reported cases of HIV-infection in Russia. Information on Gennady Roshchupkin, an AIDS activist and an AIDS victim; Activities of Russians which are putting them at danger of contracting the disease; When the first case of HIV was...

  • Tanzania plans to establish a special fund for HIV/AIDS.
    Zimmerman, Carlota // African Business News; 4/26/2013, p19 

    The article reports on the plan of Tanzania to create a special fund for human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) that will lead to a decline in its dependence on external donors by half.

  • Tokyo.
    Zimmerman, Carlota // Time International (South Pacific Edition); 03/04/96, Issue 10, p14 

    Reports on the controversies over the use of human immunodeficiency virus (HIV) tainted blood in Tokyo, Japan. Reference to a file which was revealed by Health and Welfare Minister, Naoto Kan; Number of Japanese who were infected with HIV after the use of the HIV-infected blood; Comments from...

  • `Dad, I'm HIV positive.'
    Schoch, Russell // Newsweek; 8/17/1992, Vol. 120 Issue 7, p9 

    Opinion. Examines the author's reaction to the news that his hemophiliac son had contracted the HIV virus. Why he and his son strongly support the effort to re-examine the hypothesis that HIV causes AIDS; Determination to help his son live a life that is as long and as full as it can be.

  • HIV funds dry up.
    Schoch, Russell // New Scientist; 1/11/92, Vol. 133 Issue 1803, p16 

    Reports that health officials in cities across the United States fear they may run out of funds for HIV testing within weeks. Demand for testing which rose after Earvin `Magic' Johnson announced he was infected; Cities affected; Number of calls daily at the CDC's National AIDS Hotline.

  • The sugarcoated virus.
    Gadsby, P. // Discover; Jul88 Supplement, Vol. 9 Issue 7, p30 

    Examines the AIDS virus' outer membrane. How the glycoproteins confuse the body's immune system infect cells and pose new problems for developing a vaccine.

  • Diversity equals death.
    Nowak, R. // Discover; May92, Vol. 13 Issue 5, p16 

    Presents a new theory from two mathematical biologists, Robert May and Martin Nowak of Oxford University, who say that the human immunodeficiency virus (HIV) causes AIDS by quickly diversifying into more strains than the body's immune system can handle. Analysis of HIV-infected immune system as...

  • Aids update.
    Geraci, Ron; Swierczynski, Duane // Men's Health; Feb97, Vol. 12 Issue 1, p33 

    Presents an update about AIDS. Undetectable HIV in women's vaginal secretions; Importance of exercise for HIV patients; Drug for treating `wasting syndrome'; Why patients suffering from HIV related symptoms should tell physicians about their sexual history.

  • France will compensate.
    Aldhous, P. // Nature; 12/12/1991, Vol. 354 Issue 6353, p425 

    Announces that the French government, bowing to public and media pressure, will provide compensation to about 7,000 citizens who have been infected with human immunodeficiency virus (HIV) through blood products and transfusions. Reaction of Bruno de Langre, president of the French Haemophila...

  • Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.
    Phillips, R.E.; Rowland-Jones, S. // Nature; 12/12/1991, Vol. 354 Issue 6353, p453 

    Discusses a longitudinal study of human immunodeficiency virus (HIV) seropositive patients in which there were fluctuations in the specificity of cytotoxic T cells for the virus. Describes detailed investigations of cytotoxic T lymphocytes (CTL) recognition of `gag' in six individuals, all of...

  • Prevention of HIV-1 IIIB infection in chimpanzees by CD4 immunoadhesin.
    Ward, R.H.R.; Capon, D.J. // Nature; 8/1/1991, Vol. 352 Issue 6334, p434 

    Investigates whether soluble CD4 analogues can protect an individual from challenge with human immunodeficiency virus (HIV). Uses a chimpanzee model system of cell-free HIV infection; Results; Discussion.

  • Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys.
    Putkonen, P.; Thorstensson, R. // Nature; 8/1/1991, Vol. 352 Issue 6334, p436 

    Investigates whether a transfer of antibodies can prevent human immunodeficiency virus type 2 (HIV-2) and simian immunodeficiency virus of sooty mangabey origin (SIVsm) infection in cynomolgus monkeys. Experimental methods; Results; Discussion.

  • Caring for people with AIDS in rural Africa.
    Chaava, Thebisa Hamukom // World Health; Sep/Oct96, Vol. 49 Issue 5, p18 

    Relates how communities and families shares responsibility with local hospitals for caring for people with HIV and Acquire Immune Deficiency Syndrome (AIDS) in several rural areas of Africa. Keys to both care and prevention; How Salvation Army Hospital in rural Zambia responded to the challenge...

    Chaava, Thebisa Hamukom // Xtra (Toronto); 5/31/2012, Issue 720, p20 

    The article chronicles events concerning HIV/AIDS and Toronto People with AIDS Foundation (PWA) in Ontario including the establishment of the PWA Coalition in 1986, released of the first anti-HIV drug, AZT in 1987 and opening of the fifth international AIDS Conference in Montreal, Quebec in 1989.

  • Superantigen implicated in dependence of HIV-1 replication in T cells on TCR V beta expression.
    Laurence, Jeffrey; Hodtsev, Andrew S. // Nature; 7/16/1992, Vol. 358 Issue 6383, p255 

    Presents evidence that human CD4 T-cell lines expressing selected T-cell antigen receptor V beta gene products can all be infected in vitro with HIV-1, but give markedly different titres of HIV-1 virion production. Pathogenesis of AIDS; More.

  • Bad blood.
    Laurence, Jeffrey; Hodtsev, Andrew S. // New Scientist; 4/18/92, Vol. 134 Issue 1817, p11 

    Reveals that five to ten times as many people have been infected with HIV after a blood transfusion in France than in neighboring countries. Reasons for the difference; Trial of four people charged in connection with France's blood transfusion scandal has been set for June 22.

  • A highly divergent HIV-2-related isolate.
    Dietrich, U.; Adamski, M. // Nature; 12/21/1989, Vol. 342 Issue 6252, p948 

    Describes a human immunodeficiency virus type 2 (HIV-2)-related isolate, HIV-2D205, from a healthy Ghanaian woman that is genetically equidistant to the prototypic HIV-2 strains and to sooty mangabey virus (SIVsm) and the simian immunodeficiency virus from rhesus macaques (SIVmac). Methods;...

  • Potential of community-wide chemotherapy or immunotherapy to control the spread of HIV-1.
    Anderson, R.; Gupta, S. // Nature; 3/28/1991, Vol. 350 Issue 6316, p356 

    Demonstrates, through the use of mathematical models, that community treatment with antiviral drugs or immunotherapies that lengthen the incubation period of AIDS without reducing the infectiousness of treated individuals, can increase the rate atwhich HIV-1 infection spreads and can increase...

  • Babies who beat AIDS.
    Anderson, R.; Gupta, S. // Discover; Jun96, Vol. 17 Issue 6, p30 

    Reports on HIV-infected children who somehow rid themselves of the virus. Inheritance of maternal antibodies; Proof of infection; Search for fragments of the virus itself; Possible explanations on how the children were able to beat AIDS.

  • CDC Advocates Routine Testing and Counseling — But Only If Confidential.
    Walter, Dave // Advocate; 9/29/87, Issue 482, p17 

    Reports on the guidelines issued by the Centers for Disease Control on HIV antibody testing in the U.S. Use of routine testing and counseling to encourage safer sex behavior; Controversial issues addressed by the guidelines.

  • How long does HIV survive?
    M.O.R. // Cortlandt Forum; 12/20/95, Vol. 8 Issue 12, p72 

    Focuses on how long the human immunodeficiency (HIV) virus survives outside the human body. Disinfectant for HIV.

  • French HIV tests.
    M.O.R. // New Scientist; 4/11/92, Vol. 134 Issue 1816, p12 

    Reveals that the French health ministry has ruled out any form of compulsory HIV testing. Instead it has launched a new campaign to encourage voluntary screening; National bodies that were consulted; How they will encourage voluntary screening.

  • Anonymous no more.
    M.O.R. // Advocate; 9/20/94, Issue 664, p15 

    Reports on the decision of the North Carolina state health department to require HIV antibody test subjects to furnish their names and address on a confidential basis.

  • The crisis to come.
    Kaminski, Matthew; Palchikoff, Kim // Newsweek; 4/14/1997, Vol. 129 Issue 15, p44 

    Looks at the growing AIDS epidemic in the nations of the former Soviet Union. Prostitution and drug use helping to spread the disease; Lack of knowledge about HIV and AIDS in the former Soviet Union; Quality of medical care and facilities in the area; Estimated number of unreported cases of HIV...

  • HIV `superstrain' edges into Britain.
    Day, Michael // New Scientist; 8/03/96, Vol. 151 Issue 2041, p4 

    Reports on a strain of HIV that could accelerate the spread of AIDS among heterosexuals in Britain. Inability of the Public Health Laboratory Service to monitor the spread of the strain; Variant of subtype E which is endemic in Asia; Preferential spread of subtype E by heterosexual contact.

  • HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor.
    McKeating, J.A.; Griffiths, P.D. // Nature; 2/15/1990, Vol. 343 Issue 6259, p659 

    Demonstrates that the Fc portion of immunoglobulins induced by cytomegalovirus allow immune complexes of human immunodeficiency virus (HIV) to infect fibroblasts otherwise not permissive to HIV infection. Methods; Results; Discussion.

  • Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro.
    Daly, T.J.; Cook, K.C. // Nature; 12/14/1989, Vol. 342 Issue 6251, p816 

    Demonstrates that the Rev protein, purified from `Escherichia coli,' binds in a sequence-specific manner to the Rev-responsive element in vitro. Methods; Results; Discussion.

  • Rage and confusion hide role of HIV.
    Maddox, J. // Nature; 5/21/1992, Vol. 357 Issue 6375, p188 

    Reports that Dr. Peter Duesberg's argument that HIV is not the cause of AIDS did not gain any ground at a recent alternative AIDS conference. The small army of followers who believe in his message; Martien Brands, the originator of the conference; Apparent differences in data between the...

  • Trapped but still dangerous.
    Schrager, Lewis K.; Fauci, Anthony S. // Nature; 10/26/1995, Vol. 377 Issue 6551, p680 

    Reports on the sinister survival strategy of the human immunodeficiency virus (HIV) even in the presence of antibodies that would otherwise neutralize its infectivity. Factors implicated in the development of HIV-infected diseases; Extracellular t rapping of viral particles on follicular...

  • HIV's harpoon.
    Jose, Glausiusz // Discover; Jan98, Vol. 19 Issue 1, p90 

    Reports on studies on how the HIV virus penetrates and infects cells. Similarity with flu viruses; Coreceptors used by the HIV virus.

  • Prophylaxis following occupational exposure to HIV.
    Kirchner, Jeffrey T. // American Family Physician; 4/1/1998, Vol. 57 Issue 7, p1672 

    Presents a summary of the article `A case-control study of HIV seroconversion in health care workers after percutaneous exposure,' by D.M. Cardo from the New England Journal of Medicine dated November 1997.

  • Russian records rise in HIV.
    Kirchner, Jeffrey T. // Nature; 1/9/1997, Vol. 385 Issue 6612, p108 

    Reports that during 1996 Russia experienced an increase in the number of recorded instances of new HIV carriers. The cause of the majority of cases.

  • Sleep disturbances in HIV may be signs of depression.
    Kirchner, Jeffrey T. // Psychotherapy Letter; Jan96, Vol. 8 Issue 1, p7 

    Reports that a study shows that HIV-infected patients with signs of fatigue and insomnia are indicators of psychological disturbance.

Previous 50 Results Next 50 Results
That might join me putting you to

Other Topics